10967/261 - QDB Compounds

QsarDB Repository

Zukić, S.; Osmanović, A.; Harej, A.; Kraljević Pavelić, S.; Špirtović-Halilović, S.; Veljović, E.; Roca, S.; Trifunović, S.; Završnik, D.; Maran, U. Data driven modelling of substituted pyrimidine and uracil-based derivatives validated with newly synthesized and antiproliferative evaluated compounds. Int. J. Mol. Sci. 2024, 25, 9390

Compound

ID:T28
Name:CHEMBL388691
Description:
Labels:Train
CAS:
InChi Code:InChI=1S/C30H28N2O6/c1-2-3-14-24-17-23-18-32(30(34)31-28(23)37-24)16-15-25-26(35-19-21-10-6-4-7-11-21)27(29(33)38-25)36-20-22-12-8-5-9-13-22/h4-13,15,17-18H,2-3,14,16,19-20H2,1H3/b25-15-

Properties

pIC50: Antiproliferative activity [-log(uM)] i

ValueSource or prediction
4.77

Gazivoda, T.; Šokčević, M.; Kralj, M.; Šuman, L.; Pavelić, K.; De Clercq, E.; Andrei, G.; Snoeck, R.; Balzarini, J.; Mintas, M.; Raić-Malić, S. Synthesis and Antiviral and Cytostatic Evaluations of the New C-5 Substituted Pyrimidine and Furo[2,3-d]pyrimidine 4‘,5‘-Didehydro-L-ascorbic Acid Derivatives. Journal of Medicinal Chemistry 2007, 50, 4105–4112. http://dx.doi.org/10.1021/jm070324z

4.77724

Eq.1: QSAR model for for antiproliferative activity for HeLa cells (Training set)